| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454729 | Lung Cancer | 2016 | 6 Pages |
Abstract
Our results suggest that either gemcitabine-oxaliplatin or 5-fluorouracil-oxaliplatin combinations are attractive chemotherapy regimen in metastatic pulmonary carcinoid tumors.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
T. Walter, D. Planchard, K. Bouledrak, J.Y. Scoazec, P.J. Souquet, A.S. Dussol, J. Guigay, V. Hervieu, A. Berdelou, M. Ducreux, D. Arpin, C. Lombard-Bohas, E. Baudin,